Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Newbridge NBRG Up 061 Is There More Room to Run 20260514 Telix TLX Stock Today Drops 058 Key Support at 971 20260519 Biotech Sector Faces Pressure But Select Leaders Emerge as Standouts Microsoft Feared OverReliance on OpenAI Trial Testimony Reveals Sensex Dips 135 Points Nifty Holds Above 23650 Mid and SmallCap Stocks Outperform Bezos Casts Doubt on Ambitious Timeline for Space Data Centers Amid AI Energy Demand Mattel MAT Falls 140 Watching 1405 Support 20260520 US Antitrust Case Targets Chinese Shipping Container Cartel Following TrumpXi Summit Dont Let Tax Savings Dictate Retirement Moves Hidden Costs of NoIncomeTax States AMAs 2026 Return to Las Vegas Queen Latifah Hosts BTS Appearance Could Boost Media and Tourism Accenture and HUMAIN Join Forces to Drive AI Transformation in Saudi Arabia Suzlon Energy Q4 Revenue Surges 45 as Order Book Reaches 5892 MW MT Bank Stock Wall Street Sentiment Remains Mixed Amid Regional Banking Dynamics AMD Commits 10 Billion to Taiwan AI Infrastructure for Advanced Chip Development UHT Q1 2026 Earnings Realty Trust Posts Modest Profit Amid Flat Revenue Trends VLTO Q1 2026 Earnings EPS Beats Estimates by 435 as Operational Efficiency Shines InnovAge Q1 2026 Earnings Deep EPS Miss Sends Shares Lower BP Q1 2026 Earnings Earnings Beat Estimates Amid Weaker Market Sentiment EDUC Q1 2026 Earnings Educational Development Corporation Reports Loss Amidst Unclear Revenue Picture Understanding HELOCs A Flexible Home Equity Borrowing Option SEBI Proposes Overhaul of IPO Price Discovery Mechanism Amid Distortion Concerns SCCO Q1 2026 Earnings Strong Earnings Beat Drives Share Gains Nvidia Stock Declines After Earnings Why Market Sellers May Be Overlooking the Bigger Picture Dollar General Q1 2026 Earnings EPS Surges Past Estimates on Resilient Consumer Demand Shares Edge Higher NTHI Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Development